NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Lorna T. Sniegoski, Jocelyn L. Prendergast, Michael J. Welch, Alim A. Fatah, M Gackstetter, R. Q. Thompson
Abstract
Several point-of-collection (POC) devices for detection of drugs of abuse in oral fluid were studied. The ability of the devices to meet the manufacturers' claims and their practical application to detection of drugs of abuse at low concentrations in oral fluid were evaluated. Human saliva fortified with known quantities of cocaine, phencyclidine (PCP), codeine, morphine, amphetamine, methamphetamine, and (±)-11-nor-9-carboxy-∆9-tetrahydrocannabinol (carboxy-THC), was used in the analysis. Each device was also tested for cross-reactivity with a number of common orally administered, over the counter medications, as well as substances which could be expected to occur in human saliva. In general, the POC devices performed close to their specifications, with a few exceptions. In some cases, the design of the device could make interpretation of the results unreliable or uncertain.
Sniegoski, L.
, Prendergast, J.
, Welch, M.
, Fatah, A.
, Gackstetter, M.
and Thompson, R.
(2009),
Evaluation of Oral Fluid Testing Devices, NIST Interagency/Internal Report (NISTIR), National Institute of Standards and Technology, Gaithersburg, MD, [online], https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=902366
(Accessed October 11, 2025)